Fluoxetine treatment promotes functional recovery in a rat model of cervical spinal cord injury
Manuela Scali, Tatjana Begenisic, Marco Mainardi, Marco Milanese, Tiziana Bonifacino, Giambattista Bonanno, Alessandro Sale, Lamberto Maffei, Manuela Scali, Tatjana Begenisic, Marco Mainardi, Marco Milanese, Tiziana Bonifacino, Giambattista Bonanno, Alessandro Sale, Lamberto Maffei
Abstract
Spinal cord injury (SCI) is a severe condition leading to enduring motor deficits. When lesions are incomplete, promoting spinal cord plasticity might be a useful strategy to elicit functional recovery. Here we investigated whether long-term fluoxetine administration in the drinking water, a treatment recently demonstrated to optimize brain plasticity in several pathological conditions, promotes motor recovery in rats that received a C4 dorsal funiculus crush. We show that fluoxetine administration markedly improved motor functions compared to controls in several behavioral paradigms. The improved functional effects correlated positively with significant sprouting of intact corticospinal fibers and a modulation of the excitation/inhibition balance. Our results suggest a potential application of fluoxetine treatment as a non invasive therapeutic strategy for SCI-associated neuropathologies.
Figures
References
- Thuret S., Moon L. D. F. & Gage F. H. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 7, 628–43 (2006).
- Malberg J. E., Eisch A. J., Nestler E. J. & Duman R. S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20, 9104–10 (2000).
- Hajszan T., MacLusky N. J. & Leranth C. Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus. Eur J Neurosci 21, 1299–303 (2005).
- Maya Vetencourt J. F. et al. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 320, 385–8 (2008).
- Li W. L., Cai H. H., Wang B. & Chen L. Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke. J Neurosci Res 87, 112–22 (2009).
- Narushima K., Paradiso S., Moser D. J., Jorge R. & Robinson R. G. Effect of antidepressant therapy on executive function after stroke. Br. J. Psychiatry 190, 260–5 (2007).
- Cirrito J. R. et al. Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans. Proc Natl Acad Sci USA 108, 14968–73 (2011).
- Chollet F., Tardy J., Albucher J. F. & Thalamas C. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 10, 123–30 (2011).
- Berton O. & Nestler E. J. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7, 137–51 (2006).
- Baudry A., Mouillet-Richard S., Schneider B., Launay J. M. & Kellermann O. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 329,1537–41 (2010).
- Bradbury E. J. et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636–640 (2002).
- García-Alías G., Barkhuysen S., Buckle M. & Fawcett J. W. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat Neurosci 12, 1145–51 (2009).
- Montoya C. P., Campbell-Hope L. J., Pemberton K. D. & Dunnett S. B. The ‘staircase test': a measure of independent forelimb reaching and grasping abilities in rats. J Neurosci Methods 36, 219–28 (1991).
- Metz G. A. & Whishaw I. Q. The ladder rung walking task: a scoring system and its practical application. J Vis Exp 28, 10.3791/1204. (2009).
- de Medinaceli L., Freed W. J. & Wyatt R. J. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Exp Neurol 77, 634–43 (1982).
- Brooks S. P. & Dunnett S. B. Tests to assess motor phenotype in mice: a user's guide. Nat Rev Neurosci 10, 519–29 (2009).
- Baroncelli L. et al. Brain plasticity and disease: a matter of inhibition. Neural Plast 2011, 10.1155/2011/286073 (2011).
- Bavelier D., Levi D. M., Li R. W., Dan Y. & Hensch T. K. Removing Brakes on Adult Brain Plasticity: From Molecular to Behavioral Interventions. J Neurosci 30, 14964–71 (2010).
- Chen J. L. et al. Structural basis for the role of inhibition in facilitating adult brain plasticity. Nat Neurosci 14, 587–94 (2011).
- Mainardi M. et al. Environmental enrichment potentiates thalamocortical transmission and plasticity in the adult rat visual cortex. J Neurosci Res 88, 3048–59 (2010).
- Boulenguez P. & Vinay L. Strategies to restore motor functions after spinal cord injury. Curr Opin Neurobiol 19, 587–600 (2009).
- Weidner N., Ner A., Salimi N. & Tuszynski M. H. Spontaneous corticospinal axonal plasticity and functional recovery after adult central nervous system injury. Proc Natl Acad Sci USA 98, 3513–8 (2001).
- D'Sa C. & Duman R. S. Antidepressants and neuroplasticity. Bipolar Disord 4, 183–94 (2002).
- Chang Y. C. et al. Early-life fluoxetine exposure reduced functional deficits after hypoxic-ischemia brain injury in rat pups. Neurobiol Dis 24, 101–13 (2006).
- Hannila S. S. & Filbin M. T. The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury. Exp Neurol 209, 321–32 (2008).
- Weishaupt N., Blesch A. & Fouad K. BDNF: the career of a multifaceted neurotrophin in spinal cord injury. Exp Neurol 238, 254–64 (2012).
- Merkler D. et al. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci 21, 3665–73 (2001).
- Preskorn S. H. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects onoxidative drug metabolism. Clin Pharmacokinet 32, 1–21 (1997).
- Caccia S., Cappi M., Fracasso C. & Garattini S. Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology (Berl) 100, 509–14 (1990).
Source: PubMed